| （単位：千ドル） | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 17,839 | 24,825 | 34,311 | 16,068 | 6,099 | 7,924 | 11,254 | 29,431 | 27,762 | 22,565 |
| 営業費用 | 26,498 | 39,512 | 51,966 | 43,096 | 21,034 | 14,902 | 21,439 | 41,672 | 43,045 | 36,321 |
| 営業利益 | -26,499 | -39,513 | -51,967 | -43,097 | -21,035 | -14,903 | -21,440 | -41,673 | -43,046 | -36,322 |
| 経常（税引前）利益 | -29,187 | -40,667 | -53,446 | -43,650 | -7,381 | -14,848 | -21,435 | -42,054 | -44,349 | -38,480 |
| 法人税等合計 | -1,108 | -1,846 | -2,587 | -2,782 | 381 | 0 | -4,500 | -1,200 | -1,400 | -900 |
| 実効税率（％） | ||||||||||
| 純利益 | -28,079 | -38,821 | -50,860 | -40,869 | -6,999 | -14,848 | -16,919 | -40,855 | -42,943 | -37,611 |
| 一株あたり利益 | - | - | - | - | - | - | -0.66 | -1.43 | -1.39 | -1.03 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -0.66 | -1.43 | -1.39 | -1.03 |
| EBITDA | - | - | - | - | - | - | - | - | - |